The first men have been tested as part of a landmark UK trial into the future of prostate cancer screening.
The Transform trial, funded by Prostate Cancer UK and the National Institute for Health and Care Research (NIHR), could give results and lead to changes in as little as two years.
Experts hope it will inform the future of population-wide prostate cancer screening for men by seeing which tests – such as genetic tests or 10-minute MRI scans – can be combined.
It comes as the UK national screening committee (UKNSC), which advises the Government, publishes its final guidance this week on screening men for prostate cancer.
In a draft recommendation last year, it said no to population-wide screening using the prostate specific antigen (PSA) test, saying it “is likely to cause more harm than good”.
The committee…